Eczema Free Forever™ Eczema Free Forever™

Pipeline topical reduces epidermolysis bullosa blistering

Castle Creek Pharmaceuticals announced in June 2017 that the first patient had enrolled in its phase 2/3 study assessing the safety and efficacy of its pipeline diacerein 1% ointment to treat epidermolysis bullosa simplex.
Dermatology Times – Dermatology

Considerations when examining NICU babies with blistering diseases

The neonatal intensive care unit (NICU) can be a scary place for some dermatologists, pediatric dermatologist, Sheila Fallon Friedlander, M.D., told colleagues at the MauiDerm 2016 meeting this week. She provided two key messages aimed at enabling clinicians and the babies to get the help they need. Learn and find out that they are
Modern medicine – Dermatology Times